Pneumococcal Vaccine
Conditions
Brief summary
Asia has the highest burden with the largest contribution of pneumonia burden from India. Pneumonia is also observed as 5th leading cause of deaths in India. People with diabetes with uncontrolled glucose are significantly at higher risk of development of pneumonia. Even though, pneumonia is a vaccine-preventable disease, hospitalization for pneumonia of patients with diabetes are rising. Very limited literature is available on the knowledge and practice of pneumonia vaccination among diabetologists and the rate of pneumonia vaccination received by the patients with diabetes. Hence this study aims to assess their knowledge on the same. In addition, this study also aims to identify the real barriers and facilitators of pneumococcal vaccination among diabetologists in India. A cross-sectional study will be conducted among 25diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.
Interventions
OTHERPre and Post Education on practice of pneumococcal vaccination
A cross-sectional study will be conducted among 25 diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.
Sponsors
M.V. Hospital for Diabetes
MSD Pharmaceuticals LLC
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
Diabetologists willing to participate in the study
Exclusion criteria
Unwillingness to give consent for participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify the facilitators and barriers of pneumococcal vaccination among diabetologists in India. | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| To examine the association of knowledge and practice of vaccination among diabetologists | 6 months |
| To assess the knowledge, attitude and practices of pneumococcal vaccination among select diabetologists across India. | 6 months |
| To assess the change in the knowledge of pneumococcal vaccination post educational intervention | 6 months |
Countries
India
Outcome results
None listed